Ausgabe 2/2023
Inhalt (8 Artikel)
CD44 in Bone Metastasis Development: A Key Player in the Fate Decisions of the Invading Cells?
Noy Shir Zer, Noa Ben-Ghedalia-Peled, Levi A. Gheber, Razi Vago
Belvarafenib penetrates the BBB and shows potent antitumor activity in a murine melanoma brain metastasis model
Yu-Yon Kim, Hyunjin Park, Taehun Song, Kyungjin Choi, Michael Dolton, Jialin Mao, Jisook Kim, Young Gil Ahn, Kwee Hyun Suh, Young Hoon Kim
Sufentanil combined with parecoxib sodium inhibits proliferation and metastasis of HER2-positive breast cancer cells and regulates epithelial-mesenchymal transition
Sunmian Xu, Xiaohui Li, Wenbin Li, Nina Ma, Hongjun Ma, Jian Cui, Xiaogang You, Xuexin Chen
Repurposing fluphenazine to suppress melanoma brain, lung and bone metastasis by inducing G0/G1 cell cycle arrest and apoptosis and disrupting autophagic flux
Huizhi Xi, Mengling Wu, Hongbo Ma, Shanrui Li, Qianrui Huang, Yiwen Zhang, Yong Xia
Brain metastases from hepatopancreatobiliary malignancies
Elisabeth S. Bergen, Alexander Friedrich, Peter Scherleitner, Pedro Ferreira, Barbara Kiesel, Georg Widhalm, Barbara Kiesewetter, Franziska Eckert, Gerald W. Prager, Matthias Preusser, Anna S. Berghoff
Prostate and metastasis diffusion volume based on apparent diffusion coefficient as a prognostic factor in Hormone-naïve prostate Cancer
Motohiro Fujiwara, Soichiro Yoshida, Taro Takahara, Takahiko Soma, Yuki Nakamura, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Minato Yokoyama, Yasuhisa Fujii
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results
Giulio Francolini, Michele Ganovelli, Vanessa Di Cataldo, Beatrice Detti, Saverio Caini, Mauro Loi, Gabriele Simontacchi, Isacco Desideri, Daniela Greto, Marianna Valzano, Sergio Serni, Luca Vaggelli, Viola Salvestrini, Luca Visani, Carlotta Becherini, Emanuela Olmetto, Ciro Franzese, Davide Baldaccini, Marta Scorsetti, Martina Sollini, Arturo Chiti, Icro Meattini, Richard K. Valicenti, Lorenzo Livi